Literature DB >> 28082725

Tumor suppression by p53 involves inhibiting an enabler, FGF13.

James J Manfredi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28082725      PMCID： PMC5278473          DOI： 10.1073/pnas.1619815114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

Review 1.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

Review 2.  The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.

Authors:  James J Manfredi
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

3.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

Authors:  Liz J Valente; Daniel H D Gray; Ewa M Michalak; Josefina Pinon-Hofbauer; Alex Egle; Clare L Scott; Ana Janic; Andreas Strasser
Journal:  Cell Rep       Date:  2013-05-09       Impact factor: 9.423

4.  Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.

Authors:  Colleen A Brady; Dadi Jiang; Stephano S Mello; Thomas M Johnson; Lesley A Jarvis; Margaret M Kozak; Daniela Kenzelmann Broz; Shashwati Basak; Eunice J Park; Margaret E McLaughlin; Anthony N Karnezis; Laura D Attardi
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

Review 5.  p53 and ribosome biogenesis stress: the essentials.

Authors:  Lior Golomb; Sinisa Volarevic; Moshe Oren
Journal:  FEBS Lett       Date:  2014-04-18       Impact factor: 4.124

6.  Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

Authors:  Tongyuan Li; Ning Kon; Le Jiang; Minjia Tan; Thomas Ludwig; Yingming Zhao; Richard Baer; Wei Gu
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

Review 7.  Mutant p53: one name, many proteins.

Authors:  William A Freed-Pastor; Carol Prives
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

8.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

9.  Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival.

Authors:  Débora R Bublik; Slađana Bursać; Michal Sheffer; Ines Oršolić; Tali Shalit; Ohad Tarcic; Eran Kotler; Odelia Mouhadeb; Yonit Hoffman; Gilad Fuchs; Yishai Levin; Siniša Volarević; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-19       Impact factor: 11.205

Review 10.  Signaling to p53: ribosomal proteins find their way.

Authors:  Yanping Zhang; Hua Lu
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743
View more
  3 in total

1.  FGF13 interaction with SHCBP1 activates AKT-GSK3α/β signaling and promotes the proliferation of A549 cells.

Authors:  Hongzhao Lu; Meichen Yin; Ling Wang; Jia Cheng; Wei Cheng; Huanping An; Tao Zhang
Journal:  Cancer Biol Ther       Date:  2020-10-16       Impact factor: 4.742

2.  Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer.

Authors:  Yanqiu Tong; Yang Song; Shixiong Deng
Journal:  Cancer Cell Int       Date:  2019-03-04       Impact factor: 5.722

3.  Human-derived osteoblast-like cells and pericyte-like cells induce distinct metastatic phenotypes in primary breast cancer cells.

Authors:  Vera Mayo; Annie C Bowles; Laura E Wubker; Ismael Ortiz; Albert M Cordoves; Richard J Cote; Diego Correa; Ashutosh Agarwal
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.